MIT Technology Review

The popular portrayal of computers as magic boxes capable of anything has done real societal harm. Now one TV show wants to save us.

Many genetic conditions come with clues in a person’s face, and new technology can help doctors diagnose them.

Poorly secured webcams and other Internet-connected devices are already being used as tools for cyberattacks. Can the government prevent this from becoming a catastrophic problem?

Pay-as-you-go solar systems have begun to light up homes in underserved parts of the continent, but will need to pack more punch to leapfrog the grid.

Companies are racing to develop a new type of cancer therapy, but scientists are still assessing its safety.

Companies are racing to develop a new type of cancer therapy, but scientists are still assessing their safety.

Companies are racing to develop a new type of cancer therapy, but scientists are still assessing their safety.

Technologies created by the federally funded MD2K project could lead to consumer devices that offer health guidance in real time.

We need more text and fewer videos and memes in the age of Trump.

A new book on Hewlett-Packard’s management history offers cautionary tales for today’s leading tech companies.

This year’s 13 most covetable gadgets.

By 2030, we may be gobbling turkey meat grown in bioreactors.

When a woman gets her genome sequenced, questions about privacy arise for her identical twin sister.

Joining the circulation of two mice weakened the younger one, but didn’t do much for the old one.

The defeat of carbon pricing in Washington State contrasts with its northern neighbor, where carbon taxes are now the rule.

President-elect Trump’s promise to bring back production jobs ignores the realities of advanced manufacturing.

A new study suggests that racial and gender bias affect the freelancing websites TaskRabbit and Fiverr—and may be baked into underlying algorithms.

Several companies are taking advantage of the lack of restrictions on testing autonomous vehicles in China.

The inventor of the bestselling vacuum cleaner robot has created a bot that cuts weeds.

Unable to resist any opportunity to sell you something, the e-commerce leader is opening up brick-and-mortar bookstores. But its online prowess doesn’t yet translate into a very good retail experience.

Male contraception research is a field littered with failures, but a few promising candidates are in the pipeline.

We know very few specifics about our next leader’s stance on many technology policies.

Nearly 20 percent of all election-related tweets come from an army of influential robots.

Synthetic biologists are developing genetically modified bacteria that you swallow, but no one knows yet how they should be regulated.

The Pixel phone is the tech giant’s attempt to sell high-end, highly profitable gadgets and monetize its AI investments.

The pace at which conventional chips improve is slowing, and these startups say optical computers are the answer.

A needleless, remote-controlled device for tissue expansion is awaiting FDA approval.

Hair-care company Living Proof explains how it uses biotech to develop its products.

Twenty years ago, Brian Behlendorf helped kick-start the Web—now he’s betting the technology behind Bitcoin can make the world fairer.

The billionaire is the first major donor to back the idea of creating an atlas of all human cells.

The storage company Box ratchets up its competition with Dropbox.

The coming wave of commercial drones is already exposing gaps in today’s privacy laws.

Virtual assistants that can read social cues and nonverbal signals are less jarring—and surprisingly persuasive.

The Obama administration has been touting a decrease in commercial espionage, but the reality for corporate America may be more complicated.

Will garage gene editing unleash a biological plague? Special Agent Ed You is ready if it does.

The Chinese government likes to control social media and what people do with it—but Facebook looks willing to launch in China anyway.

Greenville, South Carolina, has bet its future on high-tech manufacturing. Who wins and who loses in this increasingly automated economy?

Uber thinks its self-driving taxis could change the way millions of people get around. But autonomous vehicles aren’t any­where near to being ready for the roads.

Set aside the questions of whether it’s wise to put a wall along the U.S.-Mexico border or who should pay for it. It simply can’t be done at the price Donald Trump has claimed.

Set aside the questions of whether it’s wise to put a wall along the U.S.-Mexico border or who should pay for it. It simply can’t be done at the price Donald Trump has claimed.

Uber thinks its self-driving taxis could change the way millions of people get around. But autonomous vehicles aren’t any­where near to being ready for the roads.

Scientists are rushing to figure out how to use the gene-editing tool to stop devastating diseases like muscular dystrophy.

Scientists seek the holy grail for PTSD research: targets in the brain that could respond to drugs.

You don’t have to be Kim Kardashian to make money promoting products on social media.

Novel treatments for neurological diseases might be possible with a flexible mesh that can prod individual brain cells.

It’s time to rethink the role that government plays in shaping and supporting policies to solve big problems like climate change and income inequality.

The founder of Tesla, SolarCity, and SpaceX is deservedly admired for his technological insight. But is his latest business plan reckless?

Mobileye wants competing carmakers to contribute on-the-road data to help teach automated cars how to drive safely.

Fanuc, a company that produces robot arms for factories, is trying to get them to learn on the job.

How the search giant found itself breeding mosquitoes to try to stop the spread of the Zika virus.